Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life
Massimo Breccia; Gioia Colafigli; Matteo Molica; Emilia Scalzulli; Daniela Diverio; Roberto Latagliata; Anna Guarini; Robin Foà
Author Information: Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, Sapienza University, Rome, Italy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.